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Disparities in vascular surgery: Is it biology or
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Disparities in health care are well documented for several racial, ethnic, and gender groups. In peripheral arterial disease,
differences in prevalence, treatment selection, treatment outcomes, and resulting quality of life have negative effects on
some minority groups and women. It may be easy to document disparities, but it is harder to understand their underlying
causes. Are there biologic differences betweenmembers of racial and ethnic groups that influence disease presentation and
outcomes? Or is the socioeconomic environment that surrounds them the true driver of observed differences? This article
reviews the evidence for racial and gender disparities in vascular surgery and presents some potential mechanisms that may
explain the disparities. ( J Vasc Surg 2010;51:36S-41S.)Health disparities are differences in the quality of health
care across racial, ethnic, gender, and other demographic
categories. These disparities are most commonly seen as
differences in health care outcomes, where selected popu-
lations incur greater morbidity or mortality than other
members of the general population with the same condi-
tions. Disparities have been well documented for several
minority racial groups, ethnicities, and female gender. Al-
though inferior health care outcomes have been docu-
mented for subgroups in majority populations, the field of
disparities research focuses on minority populations be-
cause of the greater prevalence of poor health outcomes in
these groups and the implicit social goal of assisting under-
served populations.
Peripheral arterial disease (PAD) affects approximately
5 million Americans and disproportionately affects persons
who identify as black and Hispanic, those with lower in-
come, and the uninsured.1 A greater burden of atheroscle-
rotic risk factors, especially diabetes mellitus (DM), and
differential access to care may explain some of these differ-
ences. But the root causes of these disparities are not well
understood. Are there biologic differences among these
groups that affect the frequency of the disease or the
patient’s response to treatment? Or are social and environ-
mental factors related to these groups driving the effect?
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36SGenetic variations may play a limited role. Investigating
environmental factors such as insurance coverage, family
support capabilities, availability of transportation to doctor
appointments, and psychosocial stressors related to living in
a resource-poor environment will add to our understand-
ing. In many cases, members of affected groups also share
associations with environmental factors such as lower so-
cioeconomic status (SES). These coassociations make it
difficult to determine the individual contribution of biol-
ogy and environment separately. This distinction is not
only important from a mechanistic standpoint but also
helps us to design potential interventions to correct these
disparities.
DEFINING POPULATIONS AT RISK
In understanding disparities, we also have to under-
stand the populations at risk. The concept of “race” has
varied among cultures and over time. Race commonly
refers to groupings according to heritable characteristics.
The most widely used race categories are based on self-
identification and visual traits such as skin color, facial
features, and hair texture. Some argue that race definitions
are imprecise in themodern era of immigration and cultural
integration. The concept of race was first widely used
during the 15th century when European explorers sought
to colonize distant lands. In contemporary times, work in
anthropology, genetics, demography, and sociology has
given us a greater understanding of genetic and cultural
variation among humans. Many now believe that most
human differences are cultural. Beyond culture, natural
polymorphism (genetic variations that occur in different
frequencies among groups) and clines (variation over ge-
ography) have less influence over human variation.2,3
In light of controversies in the classic definitions of
race, many social scientists use the term “ethnicity” to
describe groups with self-identified shared beliefs of cul-
ture, ancestry, and history. For example, the term “His-
panic” is used to describe the culture and people of areas
formerly ruled by Spain and who speak Spanish. In the
United States, the term “Latino” refers to persons of Span-
ish heritage in the Americas and is often used interchange-
ably with “Hispanic.” Ethnic definitions span across tradi-
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clustering of human variation. However, many also recog-
nize that ethnicity is itself a social construct, sharing similar
concerns of imprecision as race definitions.4
The definitions of male and female are less controversial
than those of race and ethnicity. Human gender is deter-
mined biologically by inherited sex chromosomes, which in
turn result in gender phenotypes commonly recognizable
among all cultures. However, gender is also influenced by
personal identity and social mores. Even within conven-
tional definitions of gender, the biologic differences be-
tween genders can change over time. Notably, the protec-
tive effects of estrogen against cardiovascular disease in
young women do not appear to persist in postmenopausal
women.5
Withstanding the controversies surrounding race, eth-
nicity, and gender categorizations, this article will use com-
monly accepted terms to define these populations as well as
categories presented in original articles.6 The term “black”
is used to describe people who self-identify as “black” or
“African American” and the term “Hispanic” describes
people who self-identify as “Hispanic” or “Latino.” Be-
cause the literature uses these terms to conduct disparities
research, a summary of the topic must also accept common
usage of terms. As imprecise as these termsmay be, they still
function as recognizable descriptors for the complex pop-
ulations they represent.
DIFFERING DISEASE PREVALENCE AND
TREATMENT OF RISK FACTORS
The interaction of biology and environment in some
minority populations results in a higher prevalence of DM,
more advanced PAD at presentation, and a greater propor-
tion of women with PAD.7,8 The preponderance of chronic
diseases that are influenced by diet and physical activity,
such as type II DM, obesity, and hypertension, rather than
by conditions known to have a significant heritable compo-
nent, suggests that the disparity in risk factors is more
strongly related to environment.1,7,9-11
Few studies have described the risk profile of Hispanic
patients.12 Study participants are allowed to self-identify as
“Hispanic” in some studies, although this group may be
aggregated with others in “nonblack” or “nonwhite” cat-
egories, identified as “other,” or excluded from analysis due
insufficient numbers. These situations present a challenge
to characterizing the risk profile of Hispanic patients, with
many studies reporting conflicting results.8,13
Theremay be a synergistic interaction between race and
gender.9 Women with PAD tend to be older, are more
likely to be black, and are at a higher risk of being under-
insured or uninsured.14 Older women may have a greater
risk of PAD due to the loss of estrogen’s protective effects
after menopause. However, many of the studies that estab-
lished this effect were done in predominately white popu-
lations and the results may not be generalizable.15
Risk factor profiles. The divergence in risk factor
profiles between white, black, or Hispanic persons with
PAD extends to the medical management of cardiovasculardisease and processes of care. In populations disproportion-
ately affected by chronic disease, risk factor management is
a feasible intervention to reduce disparities. Glycemic con-
trol has been identified as a high-yield modifiable risk factor
in populations with a higher prevalence of DM.16 However
there may be differences in self-care activities among pa-
tients with DM that vary by ethnicity and contribute to
DM-related complications.17
Statin medications are underused in black patients,
especially in black men undergoing infrainguinal by-
pass.18,19 Black patients and women with PAD are under-
treated for dyslipidemia.14 Focusing on patient and pro-
vider awareness of modifiable risk factors may improve
disparities.
Specialist care. Access to specialist care for PAD and
ischemic stroke also varies by race and gender. Women,
black, and nonwhite patients are more likely to receive
care at community health centers and to have inadequate
access to cardiovascular specialists, leading to gaps in
care.14,18,20,21
Site of care. Site of care has been implicated as a
source of health care disparities in surgical outcomes. Black
and Hispanic patients and those with low income may be
more likely to receive medical care at facilities with low
volumes of vascular procedures, and this may contribute to
disproportionate mortality rates and increased risk of major
amputation for critical limb ischemia (CLI).22-24
State of disease at presentation. Advanced state of
disease at presentationmay be an indicator of inferior access
to care. Black patients with PAD present with more ad-
vanced disease and at a younger age than do white pa-
tients.7,25 Among those undergoing primary and secondary
amputation, black patients may be more likely to present
with gangrene and infection.26 Black and Hispanic patients
with cerebrovascular disease present with higher rates of
symptomatic carotid stenosis, more severe disability, and
are more frequently admitted as emergencies.27
Biologic variations in disease progression may also ex-
ist. “Small vessel” disease is more prevalent in black patients
with PAD, and this may be related to the greater burden of
hypertension and DM in this population. Intracranial oc-
clusive disease, in contrast to extracranial disease, is more
frequently found in black patients with ischemic stroke.27
The preponderance of infrageniculate disease among black
patients may contribute to the advanced stage of chronic
CLI at presentation and to inferior outcomes after infrain-
guinal bypass.8,28
DISPARITIES IN TREATMENT OUTCOMES
The disproportionate use of lower extremity amputa-
tion to treat CLI among black and Hispanic patients, those
with low income, and those with Medicaid has been well
documented in retrospective studies.25,26,29-31 Rates of
repeat lower extremity amputation are also higher among
black patients, even among those seeking care at hospitals
with significant vascular surgery capacity.25,26 Disparities in
the underuse of limb salvage procedures has remained
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underuse of carotid endarterectomy (CEA).30,32
Disparities in vascular care have a direct affect on re-
source utilization. In California, hospital charges and
length of stay for DM-related amputations were signifi-
cantly higher for black patients than for the general popu-
lation.33 Several studies have found length of stay to be
longer for black and Hispanic patients undergoing limb
salvage procedures.31,34 Black and Hispanic patients are
also at increased risk for adverse outcomes after limb salvage
procedures. A retrospective study of patients undergoing
infrainguinal bypass found higher early graft failure, worse
5-year primary patency, and lower rates of 5-year limb
salvage in black patients.7 Similar finding have been re-
ported in prospective studies.8,19
The outcomes of infrainguinal bypass in Hispanic pa-
tients may share similarities with those found in black
patients. Hispanic patients are more likely to have inferior
rates of primary patency and limb salvage than white pa-
tients and rates similar to those found in black patients.8
However, another study in a predominately Hispanic pop-
ulation of patients with PAD and DM undergoing dorsalis
pedis bypasses found no significant differences in primary
patency, assisted primary patency, or limb salvage between
Hispanic and white patients.35 Factors contributing to
disproportionate rates of amputations for CLI in Hispanic
patients have not been studied in depth but may be partly
attributed to poorly controlled DM and lack of health
insurance.36
There may be negative synergy in the risk profile for
women who identify as black. The loss of estrogen’s pro-
tective effects against cardiovascular disease in older women
may be amplified in the setting of potential biologic and
environmental variations related to racial group. Black
women are more likely to have small diameter vein grafts, a
factor associated with graft failure, and almost twice the risk
of loss of primary assisted patency and limb loss compared
with black men.19,37
Carotid stenosis. Disparities are also seen in the treat-
ment of carotid stenosis. Increased risks of perioperative
stroke and death after CEA have been found in black and
Hispanic patients.27,38 One study of a predominately black
population at two moderate-volume hospitals described
significantly higher rates of perioperative myocardial infarc-
tion, stroke, and death compared with the large North
American Symptomatic Carotid Endarterectomy Trial and
the Asymptomatic Carotid Atherosclerosis Study.39 Again,
there is evidence that site of care may affect treatment
outcomes, because black and Hispanic persons are signifi-
cantly more likely to undergo CEA at the lowest volume
hospitals and to be treated by surgeons who perform fewer
CEA procedures.27
POTENTIAL MECHANISMS OF DISPARITIES
Biology. One part of the answer to explaining dispar-
ities in vascular care is genetic variation between racial and
ethnic groups. Popular concepts of race and ethnicity fail to
account for ancestry admixture and population struc-ture.40,41 Polymorphisms associated with lipid metabolism
and type II DM in white populations are found in different
frequencies in black populations and may only confer in-
creased risk of disease in black persons who have some
European ancestry.42-44
Chronic inflammation. Racial variation in inflamma-
tory markers and the prevalence of the metabolic syndrome
is an area of active research. Chronic inflammation plays
an integral role in atherosclerosis, and higher levels of
C-reactive protein, lipoprotein(a), fibrinogen, interleukin
6, von Willebrand factor, D-dimer, and homocysteine have
been found in black patients with PAD.13,45,46 Differences
in these biomarkers are potential explanatory mechanisms
for racial disparities in PAD; however, results are inconsis-
tent between studies, and the clinical significance of these
markers of inflammation in certain demographic groups,
especially multiethnic persons and immigrants, remains
controversial.47
The prevalence of the proinflammatory state known as
the metabolic syndrome also has some racial and gender
variation. There is evidence that Mexican American and
black women share an increased risk for certain compo-
nents of the syndrome than white women, whereas the
same differences were not seen in men.48,49
Endothelial dysfunction. Differences in nitric oxide
metabolism, the response to endothelial injury, and vascu-
lar hemodynamic factors may predispose members of some
racial and ethnic minorities to PAD. Heritable abnormali-
ties in the synthesis and metabolism of nitric oxide are
associated with end-stage renal disease in black families
and may contribute to an increased risk of vascular end-
organ damage in black persons.50,51 Excess synthesis of
endothelin-1, a potent vasoconstrictor, is related to hyper-
tension in some black patients.52 Increased aortic stiffness
in black patients with PAD may be related to shear stress
and endothelial injury.53,54 The formation of keloid scars in
black persons may be related to more aggressive intimal
hyperplasia and increased graft failure in this population.55
Biologic variation by race, ethnicity, and gender
explains a small portion of the disparities in vascular care.
As the contributions of these biologic pathways to the
development of PAD in vulnerable populations are fur-
ther delineated, research focusing on interventions to
modify these risk factors will have a meaningful affect on
health disparities.
Environment. Given that race and ethnicity are asso-
ciated with SES, we propose that differences in the preva-
lence and outcomes of treatment for PAD found among
diverse racial, ethnic, and gender groups can be more fully
explained by gradients in SES. Measures of income, educa-
tion, and occupation provide a window into the complex
influence of environment on PAD across racial and gender
groups.56 Low SES, both early in life and throughout the
lifespan, has a cumulative detrimental affect on cardiovas-
cular morbidity and mortality, especially in women.57-59
SES influences access to goods and services, including
health insurance and healthful food selection at neighbor-
hood grocery stores. Genetic polymorphisms may confer a
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tant in determining phenotype and may yield modifiable
targets for intervention.
Socioeconomic status. Among some minority groups,
the combination of low income, lack of health insurance,
inability to afford medications, and the experience of per-
ceived discrimination by health care providers leads to
delays in seeking care.60,61 An individual’s culture, behav-
iors, and social networks contribute to his or her under-
standing of illness and decisions to pursue treatment.
Avoidance of care, despite having insurance, is one behav-
ior that has its roots in cultural beliefs about health and
wellness and may lead to delay in treatment and irreversible
disease progression. However, presenting for treatment
does not guarantee timely access to an intervention. One
single-institution study of patients presenting with CLI to
the emergency department or primary care clinic found that
appropriate referral to a vascular surgeon was delayed by as
much as 4 to 11 weeks.62
The metabolic syndrome. There may be a relation-
ship between SES, chronic inflammation, and the meta-
bolic syndrome. Poor health indices related to the meta-
bolic syndrome coassociate in persons who identify as black
or Hispanic and those who have low income, especially
women.48,49,63 Lower income and educational attainment
are associated with higher levels of the inflammatory cyto-
kine interleukin-6.64 Several hypotheses have been sug-
gested for the increased risk of metabolic syndrome in low
SES groups. Low-income families are more likely to con-
sume a calorically dense diet, leading to obesity and insulin
resistance.48,63 Psychosocial stressors unique to a low SES
environment have been associated with chronic inflamma-
tion and elevated cardiovascular risk. More prevalent smok-
ing in lower income groups also contributes to chronic
inflammation and atherosclerosis.63,65
The changes in diet, psychosocial stressors, and envi-
ronment that accompany the transition to Western society
are examples of how environment affects the development
of the metabolic syndrome and future cardiovascular dis-
ease. Increasing prevalence of metabolic syndrome is seen
in white, black, and Hispanic persons with successive gen-
erations of residence in the United States.66 Loss of health-
ful behaviors among Japanese Americans is accompanied by
increases in waist-hip ratio, fasting insulin level, cholesterol
and triglyceride levels, and hypertension in proportion to
generation.67 The adoption of a westernized diet among
individuals from South Asia and India has contributed to
increased insulin resistance.68 These findings support a
greater role for environment in augmenting risk.
Multiple complex environmental factors involving SES,
access to care, diet, and behavior underlie the influence that
an individual’s racial and ethnic group has been purported
to have on disparities in vascular disease. Low SES and its
incumbent economic barriers to health maintenance por-
tend increased risk of chronic inflammation, metabolic
syndrome, and subsequent cardiovascular morbidity. For-
tunately, many of these environmental driving forces of
disparities are amenable to intervention.ADDRESSING DISPARITIES
Implicating racial group as a risk factor, rather than as a
risk marker in studying disparities in vascular care, hazards
the ecologic fallacy that all people who identify as black or
Hispanic share the same risk factor profile. Racial or ethnic
categories are imprecise in their ability to describe an indi-
vidual’s environmental risk factors. Biology and environ-
ment are clearly inter-related and affect the development of
PAD, treatment decisions, and outcomes. Genetic poly-
morphisms that vary by racial group may predispose an
individual to PAD, but racial categories are not modifi-
able. Environmental factors related to SES are the major
driving forces behind disparities in PAD and are targets
for intervention.
At the level of the individual, potential interventions
include changing behaviors and diet to prevent metabolic
syndrome, supporting services that provide transportation
to doctor appointments, andmore aggressive medical man-
agement of high-risk patients, especially those with DM.
Patient navigators, supervised walking programs, and
health care coaches for chronic diseases related to PADmay
be inexpensive ways to engage patients in their care. Coor-
dinating nursing, physical therapy, and home health care
for patients with low family support or who live alone may
decrease the risks of extended length of stay, nonroutine
discharge, and preventable readmission. Elevating public
awareness of PAD, diabetic foot care, and the importance
of diet and exercise may also increase health literacy about
PAD.
On a systems level, possible solutions are provider
education to increase awareness and implementation of
screening protocols for PAD in vulnerable populations with
low SES, changing referral patterns to facilitate early refer-
ral to vascular specialists, and improving timeliness and
appropriateness of health care delivery. Interventions that
address disparities in access to specialist care and unify
primary care providers, podiatrists, and vascular surgeons
have demonstrated a decrease in amputation rates, foot
operations, hospitalizations, length of stay, emergency de-
partment visits, and missed work days.69,70 Increasing fi-
nancial support for centers in medically underserved areas
and fostering relationships between under-resourced facil-
ities and those with more robust vascular surgery capabili-
ties may improve limb salvage.
CONCLUSIONS
The existence of disparities affecting black and His-
panic patients with PAD has been well documented. How-
ever, focusing on racial variation alone as the source of poor
health outcomes relies on the use of artificial definitions to
categorize patients and assign levels of risk while neglecting
the powerful and complex effects of environment and SES.
By defining the environmental factors that drive disparities
in vascular care, we have identified potential interventions
that will improve outcomes for the most vulnerable patient
populations affected by PAD. We hope future investigators
JOURNAL OF VASCULAR SURGERY
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